Salmon calcitonin: a review of current and future therapeutic indications.

Chesnut, C H; Azria, M; Silverman, S; Engelhardt, M; Olson, M; Mindeholm, L

Chesnut, C H; Azria, M; Silverman, S; Engelhardt, M; Olson, M; Mindeholm, L.

Affiliation

Chesnut CH; Osteoporosis Research Group, University of Washington, Seattle, WA, USA. chesnut@u.washington.edu

Osteoporos Int ; 19(4): 479-91, 2008 Apr.

Article in En | MEDLINE | ID: mdl-18071651

Subject(s)

Bone Density Conservation Agents/therapeutic use; Bone Density/drug effects; Bone Resorption/metabolism; Calcitonin/therapeutic use; Osteoporosis, Postmenopausal/drug therapy; Spinal Fractures/prevention & control; Adult; Aged; Bone Density/physiology; Bone Density Conservation Agents/pharmacology; Bone Resorption/physiopathology; Calcitonin/pharmacology; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Middle Aged; Osteitis Deformans/drug therapy; Osteoporosis, Postmenopausal/physiopathology; Parathyroid Hormone/metabolism; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Resorption / Calcitonin / Bone Density / Osteoporosis, Postmenopausal / Spinal Fractures / Bone Density Conservation Agents Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2008 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links